The California-based company was founded in 2014 and offers endovenous radiofrequency ablation therapy, which is minimally invasive and provides real-time procedure data to inform treatment decisions. Their therapy is designed to close damaged veins and restore healthy blood flow in patients. Venclose aims to improve the physician and patient experience during chronic venous insufficiency treatment by commercializing the next-generation RF therapy.